Zubiri lends support for call to place Mega Manila under 2-week ECQ | Inquirer News

Zubiri lends support for call to place Mega Manila under 2-week ECQ

/ 09:11 PM August 02, 2020

MANILA, Philippines — Sen. Juan Miguel Zubiri has lent his support to the call of medical frontliners for a two-week lockdown, citing Sunday’s record high of more than 5,000 cases reported in a single day.

“I totally support the medical frontliners call for a time out for an ECQ of 15 days to stop the spread of this virus. Last time we were on ECQ we had an average of just 200 cases a day. Today at GCQ, it’ an average 3,000 to 4,000 cases a day. I pity the doctors and nurses in our hospitals that have reached their capacity,” Zubiri said.

He added that a friend who had COVID-19 was turned away due to a lack of beds, and passed away on Saturday due to a lack of respirator.

“I understand the importance of the economy and businesses, especially those who will lose jobs. But for a successful economy, our workers must remain safe,” Zubiri said.

/MUF
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, ECQ, frontliners

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.